Skip to main content

Background


The modulation of hydrogel for controlled therapeutic release maintains an objective to deliver and control the release of therapeutics utilizing a hydrogel delivery system derived from sodium alginate. The therapeutic-infused hydrogel adhesive for controlled release intends to offer treatment for first and second degree burns. The hydrogel alginate complex of the proposed wound dressing rectifies the compromised water barriers which incur from instances of first and second degree burns. As such, the hydrogel alginate complex releases a therapeutic agent into the burn wound while simultaneously hydrating the area, thus averting further injury. The hydrogel wound dressing will be generated by precipitating food-grade sodium alginate in a calcium chloride solution. The reaction will yield spheres of low-density gel encompassed by a thin, gelatinous membrane. Both  high-density and low-density hydrogel layers will be produced, then fashioned between the low-density hydrogel spheres, before the dressing undergoes a freeze-drying process as to produce porous sheets. Pre-existing treatment of first-degree and second-degree burns call for the application of lidocaine anesthetic with aloe vera gel or cream to soothe the infected area. Likewise, an antibiotic ointment may be utilized to further protect the infected area. The hydrogel wound dressing provides for the soothing sensation, typically achieved by pre-existing solutions, with the sterility and protection of pre-existing antibiotic treatments. Consequently, the hydrogel wound dressing functions as comparatively more sterile, efficient treatment of burn wounds.


The video illustrates the production of hydrogel 'beads' and 'worms' utilizing sodium alginate and calcium chloride

Comments

Post a Comment

Popular posts from this blog

Week Five Progress

During week five, more research was done and the group was able to decide on the exact concentrations of calcium chloride to use in making each hydrogel layer as well as in the beads. The higher the concentration of calcium chloride, the more dense the hydrogel layer will be. Thus, for the thin, low-density layer, as well as for the low-density beads, a 5% calcium chloride solution will be used. For the thick, high-density layer, a 7% calcium chloride solution will be used. Refer to Figure 1, below, for a visual of the design. Figure 1: Preliminary Diagram of the Hydrogel Wound Dressing   Another task that was completed this week was additional planning for the testing phase. Once the hydrogel has been constructed, samples of it will be placed into cuvettes, and fluorescently-labeled bovine serum albumin (FITC-BSA) will be injected into the cuvettes, one at a time, in intervals of four hours. This will occur over a period of two days, and at the end of the two day...
Post a Comment
Read more

Week Three Progress

During Week Three, we discussed and determined our therapeutic agent for the hydrogel module. After extensive research and comparison of our options, we decided the best-suited therapeutic would be zinc oxide. This substance fits our design so well because it is hydrophobic and will slowly disperse through the pores in the bottom hydrogel layer. Zinc oxide has been used in past hydrogel models and has been proven to be effective. It is an agent that has been used in ointments and supplements to treat burns and prevent infections. Likewise, the possibility of overdosing on zinc-oxide necessitates a solution for controlled therapeutic release. The predominant delivery system for zinc oxide is through medicinal cream, the delivery through which enables the therapeutic threshold of zinc oxide to be increased to levels of high toxicity. Symptoms of zinc-oxide overdose include: fever, chills, vomiting, mouth irritation, stomach pain, and yellowing of the eyes and skin. Consequently, the phar...
Post a Comment
Read more

Week Four Progress

Our focus this week was finding the correct placebo for our design. Prior to this week, we had expected to use zinc oxide in our module but we realized it did not have a high enough molecular weight. Therefore, the zinc oxide would disperse from the hydrogel beads too rapidly. After some research and guidance from our professor, we decided to use Fluorescein Isothiocyanate-Bovine Serum Album (FITC-BSA), which is a hydrophilic protein with a molecular weight of 66 kg/mol [1]. FITC-BSA will also be our signal source for measuring the rate of dispersion from the beads. As seen in Figure 1, FITC-BSA is vivid in color and allows the protein's diffusion throughout the hydrogel to be observed easily. We've decided to initially use 0.25 mg/ml as the concentration of FITC-BSA within our design. Figure 1: FITC-BSA (green) seen in samples of HeLa cells [2] References: [1]  Bovine Serum Albumin Conjugates Product Information , 1st ed. Molecular Probes, 2005. [2] S. Sarker, R....
Post a Comment
Read more